[Editors] Model aids understanding of protein networks
Elizabeth Thomson
thomson at MIT.EDU
Tue Jun 26 15:33:41 EDT 2007
MIT News Office
Massachusetts Institute of Technology
Room 11-400
77 Massachusetts Avenue
Cambridge, MA 02139-4307
Phone: 617-253-2700
http://web.mit.edu/newsoffice/www
======================================
Team's model aids understanding of protein networks
--Work could impact cancer research
======================================
For Immediate Release
TUESDAY, JUNE 26, 2007
Contact: Elizabeth A. Thomson, MIT News Office
Phone: 617-258-5402
Email: thomson at mit.edu
CAMBRIDGE, Mass.--An international team of researchers, including
several from MIT, has developed a computational model that helps
identify relationships between proteins and the enzymes that regulate
them.
The work could help researchers understand the complex protein
networks that influence human disease, including cancer. The
researchers report their findings in the cover story of the June 29
issue of Cell.
The new method, known as NetworKIN, can trawl through existing
research data and use it to illuminate protein networks that control
cellular processes. It focuses on enzymes called kinases, which are
involved in many cell signaling pathways, including repair of DNA
damage that can lead to cancer.
The model was developed by researchers from MIT, the Samuel Lunenfeld
Research Institute of Mount Sinai Hospital in Canada and the European
Molecular Biology Laboratory in Germany.
NetworKIN “gives us the tools to take the information we already have
and begin to build a map of the kinase signaling pathways within the
cells,” said Michael Yaffe, MIT associate professor of biology and
biological engineering, a member of MIT's Center for Cancer Research
(CCR) and one of the authors of the paper.
“By getting a network-wide view, multiple aberrant genes of kinase-
controlled processes are more easily targeted,” said Rune Linding, a
postdoctoral fellow with joint appointments through the CCR and Mount
Sinai. “In the future, complex human diseases will be treated by
targeting multiple genes.”
Kinases act by phosphorylating, or adding a phosphate group, to a
protein. That signal tells a protein what it should be doing. Yaffe
estimated that at any one time, 30 to 50 percent of the proteins in a
cell are phosphorylated.
Because kinases play such a critical role in cellular processes,
including DNA repair and cell division, scientists have been working
to identify where phosphorylation takes place in a target protein.
Mass spectrometry makes it easy to identify those sites, but until
now there has been no good way to figure out which kinases are acting
on each site, Yaffe said.
“It's a huge bottleneck,” he said. “We're getting thousands of
phosphorylation sites, but we don't know which kinase phosphorylated
them, so we don't know what pathway to put them in.”
To solve that problem, the researchers developed a two-step approach.
In the first step, they used a pair of previously developed computer
programs that can analyze the amino acid sequence of the
phosphorylation site and predict which family of kinases is most
likely to bind to and phosphorylate it.
However, each family includes several kinases, and the sequence alone
cannot tell you which one acts on the site.
To pinpoint the kinases more accurately, the researchers developed a
computational model that analyzes databases that contain information
about signaling pathways and protein interactions. The program also
performs “text mining” of published articles and abstracts to search
for reported protein-kinase interactions.
By combining these two sources of information-sequences of the target
proteins and contextual information about the interaction between
proteins and kinases-the computational model can develop a detailed
network that would be very difficult to create by manually examining
the available data.
“The sequence gets us into the ballpark, but it's all of this
contextual information that helps us figure out specifically which
kinases are acting on which sites,” said Yaffe, who is also
affiliated with the Broad Institute of MIT and Harvard, and Beth
Israel Deaconess Medical Center.
Other MIT authors on the paper are Gerald Ostheimer, a postdoctoral
fellow in biological engineering, Marcel van Vugt, a postdoctoral
fellow at the Center for Cancer Research, and Leona Samson, director
of the Center for Environmental Health Sciences and professor of
biology and biological engineering.
The research was funded by the European Commission FP6 Programme, the
Danish Research Council for the Natural Sciences, the Lundbeck
Foundation, Genome Canada and the National Institutes of Health
Integrative Cancer Biology Program.
--MIT--
Written by Anne Trafton, MIT News Office
More information about the Editors
mailing list